OOIR: Observatory of International Research

Papers

(The TQCC of Brain Tumor Pathology is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)

Article	Citations
The 2021 WHO classification of tumors, 5th edition, central nervous system tumors: the 10 basic principles	34
The molecular framework of pediatric-type diffuse gliomas: shifting toward the revision of the WHO classification of tumors of the central nervous system	22
Combination of p38 MAPK inhibitor with PD-L1 antibody effectively prolongs survivals of temozolomide-resistant glioma-bearing mice via reduction of infiltrating glioma-associated macrophages and PD-L1	20
EZH2 inhibitory protein (EZHIP/Cxorf67) expression correlates strongly with H3K27me3 loss in posterior fossa ependymomas and is mutually exclusive with H3K27M mutations	20
Prognostic significance of brain invasion in meningiomas: systematic review and meta-analysis	17
Molecular subtyping of ependymoma and prognostic impact of Ki-67	13
Ependymoma with C11orf95-MAML2 fusion: presenting with granular cell and ganglion cell features	12
Spinal cord astroblastoma with EWSR1-BEND2 fusion classified as HGNET-MN1 by methylation classification: a case report	12
The proteomic analysis shows enrichment of RNA surveillance pathways in adult SHH and extensive metabolic reprogramming in Group 3 medulloblastomas	11
Droplet digital PCR assay for detecting TERT promoter mutations in patients with glioma	11
Implications of immune cells in oncolytic herpes simplex virotherapy for glioma	11
Predicting BRAF V600E mutation in glioblastoma: utility of radiographic features	10
Prognostic significance of TERT promoter mutations in adult-type diffuse gliomas	10
Epithelioid inflammatory myofibroblastic sarcoma with VCL–ALK fusion of central nervous system: case report and brief review of the literature	10
Brain-invasive meningiomas: molecular mechanisms and potential therapeutic options	9
T2-fluid-attenuated inversion recovery mismatch sign in lower grade gliomas: correlation with pathological and molecular findings	9
Anti-angiogenic and macrophage-based therapeutic strategies for glioma immunotherapy	9
Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype: case series of a new entity	8
A novel YAP1-MAML2 fusion in an adult supra-tentorial ependymoma, YAP1-fused	8
Intracranial angiomatoid fibrous histiocytoma with rhabdoid features: a mimic of rhabdoid meningioma	8
Reliability of IDH1-R132H and ATRX and/or p53 immunohistochemistry for molecular subclassification of Grade 2/3 gliomas	8
Primary central nervous system lymphoma: clinicopathological and genomic insights for therapeutic development	8
Liquid biomarkers in glioma	7
IDH wild-type lower-grade gliomas with glioblastoma molecular features: a systematic review and meta-analysis	7
Diffusely infiltrating glioma with CREBBP–BCORL1 fusion showing overexpression of not only BCORL1 but BCOR: A case report	7

Clinical implications of molecular analysis in diffuse glioma stratification	7
Update of the 2021 WHO classification of tumors of the central nervous system: adult diffuse gliomas	7
Aggressive nonfunctioning pituitary neuroendocrine tumors	7